Predicting Lung Cancer Outcomes with Advanced Imaging
In the realm of lung cancer treatment, precision is key. A recent study took a closer look at how baseline 18F-FDG PET/CT scans could help predict outcomes for patients with stage IV non-small cell lung cancer (NSCLC). The focus was on metabolic parameters from these scans and their potential to forecast how well patients might respond to osimertinib, a targeted ther...